• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Shifting Paradigms in Thyroid Cancer Follow-Up

by Pippa Wysong • October 1, 2009

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

Generally, the role of PET scanning has expanded in the new guidelines, Dr. Cooper said. It is recognized as something that helps localize disease in Tg-positive, RAI scan-negative patients without needing to have a negative post-RAI therapy scan. PET scans should also be used for staging of disease, as a prognostic tool for patients with metastatic disease to identify those at highest risk, and for evaluation of post-treatment response.

You Might Also Like

  • New Paradigms Emerging in Diagnosis, Management of Thyroid Cancer
  • Thyroid Palpation Should Follow Serum Hormone Measurement
  • What Role Does Thyroglobulin Washout Have in Follow-Up Algorithm of Differentiated Thyroid Cancer?
  • New Guidelines Developed to Manage Thyroid Nodules and Thyroid Cancer
Explore This Issue
October 2009

The guidelines now emphasize risk-adapted management. Not only is the initial therapy directed toward the baseline risk of the patient, but the follow-up should also be based on the risk of the patient, Dr. Cooper said. This includes observing and acting on how risk changes over time in individual patients.

In low-risk patients, in the first two years of follow-up, it is now considered reasonable to obtain Tg levels every six months for the first two years. Once the stimulated Tg has been negative for a year, the test does not need to be repeated.

In patients with intermediate risk, it is reasonable to repeat stimulated Tg levels because disease will be detected in some of them-even if basal Tg is undetectable.

Ultrasound should be used yearly in low-risk patients for the first two years, but more frequently in intermediate- and high-risk patients (high-risk patients need to be intensively monitored in general). The guidelines now say that once a patient is disease-free, the serum TSH can be allowed to rise into the normal range in low-risk patients, but should remain <0.1 mU/L in intermediate- and high-risk patients. Dr. Cooper noted that the approach to thyroid hormone suppressive therapy needs to take into account other comorbidities a patient has (such as cardiovascular disease or osteoporosis) and factor those into the risk-benefit treatment profile for that patient.

I think our guidelines have helped push along the concept that once a patient has been proven to be free of disease, it is no longer necessary to keep their serum TSH suppressed, he said.

©2009 The Triological Society

Pages: 1 2 3 4 | Single Page

Filed Under: Everyday Ethics, Head and Neck, Health Policy Tagged With: head and neck cancer, patient safety, thyroidIssue: October 2009

You Might Also Like:

  • New Paradigms Emerging in Diagnosis, Management of Thyroid Cancer
  • Thyroid Palpation Should Follow Serum Hormone Measurement
  • What Role Does Thyroglobulin Washout Have in Follow-Up Algorithm of Differentiated Thyroid Cancer?
  • New Guidelines Developed to Manage Thyroid Nodules and Thyroid Cancer

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Would you choose a concierge physician as your PCP?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • A Journey Through Pay Inequity: A Physician’s Firsthand Account

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Shifting the Treatment Goalpost Toward Medical Management of Recurrent Respiratory Papillomatosis

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Excitement Around Gene Therapy for Hearing Restoration
    • “Small” Acts of Kindness
    • How To: Endoscopic Total Maxillectomy Without Facial Skin Incision
    • Science Communities Must Speak Out When Policies Threaten Health and Safety
    • Observation Most Cost-Effective in Addressing AECRS in Absence of Bacterial Infection

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939